Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer by Lohmann, Ana Elisa, Chapman, Judy-Anne W., Burnell, Margot J., Levine, Mark Norman, Tsvetkova, Elena, Pritchard, Kathleen I., Gelmon, Karen A., O’Brien, Patti, Han, Lei, Rugo, Hope S., Albain, Kathy S., Perez, Edith A., Vandenberg, Theodore A., Chalchal, Haji I., Sawhney, Ravinder Pal Singh, Shepherd, Lois E., Goodwin, Pamela Jean

Get full text